The epidemiology and prevention of hepatocellular carcinoma.
about
Hepatocellular Carcinoma in The Gambia and the role of Hepatitis B and Hepatitis C.Analysis of Risk Factors Associated with the Development of Hepatocellular Carcinoma in Chronic HBV-Infected Chinese: A Meta-AnalysisFunctional short tandem repeat polymorphism of PTPN11 and susceptibility to hepatocellular carcinoma in Chinese populationsPromising candidates for the treatment of chronic hepatitis C.Prognosis of Patients With Fibrolamellar Hepatocellular Carcinoma Versus Conventional Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.High seroprevalence of human herpesvirus type 8 in patients with hepatocellular carcinoma.Factors associated with outcomes and response to therapy in patients with infiltrative hepatocellular carcinomaSymptom management in hepatocellular carcinomaHepatitis B virus pre-S deletion mutations are a risk factor for hepatocellular carcinoma: a matched nested case-control study.Epidemiology of hepatitis C: related hepatocellular carcinoma in CameroonDiagnostic Value of Semiquantitative Analysis of Dynamic Susceptibility Contrast Magnetic Resonance Imaging with GD-EOB-DTPA in Focal Liver Lesions Characterization: A Feasibility StudyMicroarray profiling shows distinct differences between primary tumors and commonly used preclinical models in hepatocellular carcinoma.Diffuse infiltrative hepatocellular carcinoma: assessment of presentation, treatment, and outcomesHBV A1762T, G1764A mutations are a valuable biomarker for identifying a subset of male HBsAg carriers at extremely high risk of hepatocellular carcinoma: a prospective study.Radiation therapy to non-iatrogenic subcutaneous metastasis in hepatocellular carcinoma: results of a case series.The laparoscopic approach for radiofrequency ablation of hepatocellular carcinoma--indication, technique and results.Percutaneous Endovascular Radiofrequency Ablation for Malignant Portal Obstruction: An Initial Clinical Experience.Assessment of supra-additive effects of cytotoxic drugs and low dose rate irradiation in an in vitro model for hepatocellular carcinoma.Right hepatectomy for combined primary neuroendocrine and hepatocellular carcinoma. A case report.A rare cause of gastrointestinal haemorrhage: gastric invasion by hepatocellular carcinoma.Immunization of guinea pigs with novel hepatitis B antigen as nanoparticle aggregate powders administered by the pulmonary routeAssociation between hMLH1 hypermethylation and JC virus (JCV) infection in human colorectal cancer (CRC).Epidemiology and survival of hepatocellular carcinoma in Turkey: outcome of multicenter study.Hepatocellular Carcinoma and High Grade Neuroendocrine Carcinoma: A Case Report and Review of the Literature.Freshwater cyanobacterial blooms and primary liver cancer epidemiological studies in Serbia.Association between an insertion/deletion polymorphism within 3'UTR of SGSM3 and risk of hepatocellular carcinoma.Plasma levels of matrix metalloproteinase-2 and -9 in male and female patients with cirrhosis of different aetiologies.MicroRNA-21 promotes cell proliferation in human hepatocellular carcinoma partly by targeting HEPN1.
P2860
Q24815408-288FA328-BE15-4F1B-8C22-B781CA44F3A9Q26744336-F2D7111E-B6B5-4B99-9741-1A28FB85E2EBQ28542875-55530A3F-867C-4853-A149-0DA3692AC9C1Q30333233-63D0664F-A7DF-4B67-A2C6-AECCA5828F0FQ31160462-F566548A-C8B7-4362-BDBC-A19B46F85927Q33416527-54BC8E9D-4A76-4116-9E04-6273C6E87510Q33738482-0561C4C4-EC35-470B-8721-EFA37C7D4736Q33897458-897683DC-FDC9-496A-B37B-D1D4E1CCC192Q33918324-4D3A2FC8-9BFC-451B-B8F8-22D4CB6B04CFQ35593576-AED71883-0BA0-43CE-BE9B-60DB2697585AQ35625833-22FBF3C0-212C-40FD-93EC-20F4F7B7966DQ35828338-1E96B081-B31D-4EFE-9284-D2317E85B1FFQ36512761-9DC199E4-1CEE-4CDC-B252-83B7513C996FQ36935260-F4812E36-C29D-4AFB-8CC6-0ACA43475677Q37073221-7090142C-5EFC-45F8-9CDE-FE0054FAF63BQ38055031-1983DBE4-9339-415F-AC07-84A9EA86C2C9Q39947702-832B45C4-4C67-4E89-BB1D-BD94563EC762Q40183947-5D8F0696-06D2-455E-A19A-E8C2B8631503Q41900786-CFC7B9B8-CC65-419B-883E-2A9B3F23C285Q41930142-4D2C3E7D-7EAE-4EA7-BD39-35638717C6A9Q41950285-955936C6-DAFF-44ED-84FC-A151AAA696F5Q42182618-86D0D6E0-7AA1-49AD-BB16-1A1F6ADFA0CBQ42981124-E6229718-35C4-44B9-A6C9-AD7ABAF547E8Q44102790-87AE73FC-DF71-4FCF-B698-D0C3AF986C65Q45170266-010CDE93-55E4-4D5B-A4BF-04AE4A18CB2EQ47851941-5CF76D59-0301-4323-9595-252CF37AFCA1Q50998028-6FE7FDA1-42ED-4EC3-82BA-19B52528DF12Q52966535-A4D82230-D0EA-4CBC-8BF9-C8A7EC9F3D6B
P2860
The epidemiology and prevention of hepatocellular carcinoma.
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The epidemiology and prevention of hepatocellular carcinoma.
@ast
The epidemiology and prevention of hepatocellular carcinoma.
@en
The epidemiology and prevention of hepatocellular carcinoma.
@nl
type
label
The epidemiology and prevention of hepatocellular carcinoma.
@ast
The epidemiology and prevention of hepatocellular carcinoma.
@en
The epidemiology and prevention of hepatocellular carcinoma.
@nl
prefLabel
The epidemiology and prevention of hepatocellular carcinoma.
@ast
The epidemiology and prevention of hepatocellular carcinoma.
@en
The epidemiology and prevention of hepatocellular carcinoma.
@nl
P1433
P1476
The epidemiology and prevention of hepatocellular carcinoma.
@en
P2093
P304
P356
10.1016/S0093-7754(01)90137-X
P577
2001-10-01T00:00:00Z